Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2018 Sep 1;25(9):846-984.
doi: 10.5551/jat.GL2017. Epub 2018 Aug 22.

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017

Makoto Kinoshita  1 , Koutaro Yokote  2 , Hidenori Arai  3 , Mami Iida  4 , Yasushi Ishigaki  5 , Shun Ishibashi  6 , Seiji Umemoto  7 , Genshi Egusa  8 , Hirotoshi Ohmura  9 , Tomonori Okamura  10 , Shinji Kihara  11 , Shinji Koba  12 , Isao Saito  13 , Tetsuo Shoji  14 , Hiroyuki Daida  9 , Kazuhisa Tsukamoto  15 , Juno Deguchi  16 , Seitaro Dohi  17 , Kazushige Dobashi  18 , Hirotoshi Hamaguchi  19 , Masumi Hara  20 , Takafumi Hiro  21 , Sadatoshi Biro  22 , Yoshio Fujioka  23 , Chizuko Maruyama  24 , Yoshihiro Miyamoto  25 , Yoshitaka Murakami  26 , Masayuki Yokode  27 , Hiroshi Yoshida  28 , Hiromi Rakugi  29 , Akihiko Wakatsuki  30 , Shizuya Yamashita  31   32 ; Committee for Epidemiology and Clinical Management of Atherosclerosis
Affiliations
Practice Guideline

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017

Makoto Kinoshita et al. J Atheroscler Thromb. .
No abstract available

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Flowchart Using the Suita Score to Establish LDL-C Management Targets, from the Perspective of CAD Prevention • The Suita score is calculated based on Fig. 2. • Note: For patients diagnosed with FH and those diagnosed with familial type Ⅲ hyperlipidemia, do not use this chart and refer to Chapter 5 (Familial Hypercholesterolemia) and Chapter 6 (Other Types of Primary Dyslipidemias), respectively.
Fig. 2.
Fig. 2.
Model for Predicting CAD Onset Using the Suita Score * Ex-smokers should be regarded as nonsmokers. Note that the risk of CAD decreases by almost half 1 year after smoking cessation and drops to the same level as in nonsmokers after 15 years of smoking cessation. ** The current values are used even if the patient is currently undergoing treatment or not. However, counsel the patient while keeping in mind that patients undergoing treatment for hypertension have a higher risk of CAD than those who have the same blood pressure value without undergoing treatment.
Fig. 3.
Fig. 3.
Flowchart for Establishing LDL-C Management Targets from the Perspective of CAD Prevention (Simplified Version Using Risk Factors)
Fig. 4.
Fig. 4.
Relationship between the number of concurrent risk factors and death due to CAD and stroke (NIPPON DATA80: 1980–1994) Risk factors: Obesity, hypertension, hyperglycemia, hypercholesterolemia
Fig. 5.
Fig. 5.
Rerationship between the number of concurrent risk factors and incidences of CAD and cerebral infarction Components of metabolic syndrome: Obesity, impaired glucose tolerance, lipidosis, hyperttention, hyperinsulinemia After adjustment for age, 5-year (1988–1993) follow-up of 1097 men and women aged ≥ 60 years in Hisayama-cho
Fig. 6.
Fig. 6.
Comprehensive Risks and Risk Factors for Lifestyle Habits Joint Committee for Comprehensive Risk Management Chart for the Prevention of Cerebro- and Cardiovascular Diseases, The Journal of The Japanese Society of Internal Medicine 2015, Vol. 104, No. 4, 824–860
Fig. 7.
Fig. 7.
Comprehensive risk assessment and their management in six steps
Fig. 8a.
Fig. 8a.
Step 1a Screening (Basic Items)
Fig. 8b.
Fig. 8b.
Step 1b Screening (Additional Items)
Fig. 8c.
Fig. 8c.
Step 1c Determination of Necessity for Referral to a Specialist
Fig. 8d.
Fig. 8d.
Step 2 Diagnosis of Each Risk Factor and Additional Items for Assessment*
Fig. 8e.
Fig. 8e.
Step 3 Risk Factors to be Reviewed before Initiating Treatment
Fig. 8f.
Fig. 8f.
Step 4 Setting Management Targets Suited to the Risk Factors for Each Pathological Condition*
Fig. 8g.
Fig. 8g.
Step 5 Lifestyle modifications
Fig. 8h.
Fig. 8h.
Step 6 Drug Therapy*
Fig. 9.
Fig. 9.
Treatment flow chart for adult (15 years or over) heterozygous FH
Fig. 10.
Fig. 10.
Treatment flow chart for adult (15 years or over) homozygous FH
Fig. 11.
Fig. 11.
Algorithm for treatment of pediatric FH heterozygote
None
Adapted/modified from: Ministry of Health, Labour and Welfare “Exercise guidelines for health promotion 2006”
See this image and copyright information in PMC

References

    1. The joint committee of “The Japan Academy of Neurosonology” and “The Japan Society of Embolus Detection and Treatment” on guideline for nuerosonology. Carotid ultrasound examination. Neurosonology, 2006; 19: 49-67 (in Japanese)
    1. Subcommittee for preparing guidelines for ultrasound diagnosis of carotid artery. Standard method for ultrasound evaluation of carotid artery lesions. Jpn J Med Ultrasonics, 2009; 36: 501-518 (in Japanese)
    1. Subcommittee for preparing guidelines for ultrasound diagnosis of carotid artery. Standard method for ultrasound evaluation of carotid artery lesions 2017. Jpn J Med Ultrasonics, 2018. https://www.jsum.or.jp/committee/diagnostic/pdf/jsum0515_guideline.pdf (in Japanese)
    1. Homma S, Hirose N, Ishida H, Ishii T, Araki G. Carotid plaque and intima-media thickness assessed by b-mode ultrasonography in subjects ranging from young adults to centenarians. Stroke, 2001; 32: 830-835 - PubMed
    1. Nezu T, Hosomi N, Aoki S, Matsumoto M. Carotid intima-media thickness for atherosclerosis. J Atheroscler Thromb, 2016; 23: 18-31 - PubMed

Publication types